The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation

Introduction: Epidemiologic data indicate diabetes confers an augmented risk of lung cancer development, yet the relationship between hyperglycemia, metabolic agents, and prognosis is unclear. We analyzed the impact of hyperglycemia, anti-diabetic agents, and statins on outcomes in non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Iarrobino, Nick A., Gill, Beant S., Bernard, Mark, Klement, Rainer J., Werner-Wasik, Maria, Champ, Colin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072851/
https://www.ncbi.nlm.nih.gov/pubmed/30101126
http://dx.doi.org/10.3389/fonc.2018.00281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072851/
https://www.ncbi.nlm.nih.gov/pubmed/30101126
http://dx.doi.org/10.3389/fonc.2018.00281

Ejemplares similares